Cargando…
Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by excessive formation of beta-amyloid peptides (Aβ), mitochondrial dysfunction, enhanced production of reactive oxygen species (ROS), and altered glycolysis. Since the disease is currently not curable, preventive and supportive approaches are in the focus o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297858/ https://www.ncbi.nlm.nih.gov/pubmed/37373177 http://dx.doi.org/10.3390/ijms241210029 |
_version_ | 1785063972806852608 |
---|---|
author | Babylon, Lukas Meißner, Julia Eckert, Gunter P. |
author_facet | Babylon, Lukas Meißner, Julia Eckert, Gunter P. |
author_sort | Babylon, Lukas |
collection | PubMed |
description | Alzheimer’s disease (AD) is characterized by excessive formation of beta-amyloid peptides (Aβ), mitochondrial dysfunction, enhanced production of reactive oxygen species (ROS), and altered glycolysis. Since the disease is currently not curable, preventive and supportive approaches are in the focus of science. Based on studies of promising single substances, the present study used a mixture (cocktail, SC) of compounds consisting of hesperetin (HstP), magnesium-orotate (MgOr), and folic acid (Fol), as well as the combination (KCC) of caffeine (Cof), kahweol (KW) and cafestol (CF). For all compounds, we showed positive results in SH-SY5Y-APP(695) cells—a model of early AD. Thus, SH-SY5Y-APP(695) cells were incubated with SC and the activity of the mitochondrial respiration chain complexes were measured, as well as levels of ATP, Aβ, ROS, lactate and pyruvate. Incubation of SH-SY5Y-APP(695) cells with SC significantly increased the endogenous respiration of mitochondria and ATP levels, while Aβ(1–40) levels were significantly decreased. Incubation with SC showed no significant effects on oxidative stress and glycolysis. In summary, this combination of compounds with proven effects on mitochondrial parameters has the potential to improve mitochondrial dysfunction in a cellular model of AD. |
format | Online Article Text |
id | pubmed-10297858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102978582023-06-28 Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease Babylon, Lukas Meißner, Julia Eckert, Gunter P. Int J Mol Sci Article Alzheimer’s disease (AD) is characterized by excessive formation of beta-amyloid peptides (Aβ), mitochondrial dysfunction, enhanced production of reactive oxygen species (ROS), and altered glycolysis. Since the disease is currently not curable, preventive and supportive approaches are in the focus of science. Based on studies of promising single substances, the present study used a mixture (cocktail, SC) of compounds consisting of hesperetin (HstP), magnesium-orotate (MgOr), and folic acid (Fol), as well as the combination (KCC) of caffeine (Cof), kahweol (KW) and cafestol (CF). For all compounds, we showed positive results in SH-SY5Y-APP(695) cells—a model of early AD. Thus, SH-SY5Y-APP(695) cells were incubated with SC and the activity of the mitochondrial respiration chain complexes were measured, as well as levels of ATP, Aβ, ROS, lactate and pyruvate. Incubation of SH-SY5Y-APP(695) cells with SC significantly increased the endogenous respiration of mitochondria and ATP levels, while Aβ(1–40) levels were significantly decreased. Incubation with SC showed no significant effects on oxidative stress and glycolysis. In summary, this combination of compounds with proven effects on mitochondrial parameters has the potential to improve mitochondrial dysfunction in a cellular model of AD. MDPI 2023-06-12 /pmc/articles/PMC10297858/ /pubmed/37373177 http://dx.doi.org/10.3390/ijms241210029 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Babylon, Lukas Meißner, Julia Eckert, Gunter P. Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title | Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title_full | Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title_fullStr | Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title_full_unstemmed | Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title_short | Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease |
title_sort | combination of secondary plant metabolites and micronutrients improves mitochondrial function in a cell model of early alzheimer’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297858/ https://www.ncbi.nlm.nih.gov/pubmed/37373177 http://dx.doi.org/10.3390/ijms241210029 |
work_keys_str_mv | AT babylonlukas combinationofsecondaryplantmetabolitesandmicronutrientsimprovesmitochondrialfunctioninacellmodelofearlyalzheimersdisease AT meißnerjulia combinationofsecondaryplantmetabolitesandmicronutrientsimprovesmitochondrialfunctioninacellmodelofearlyalzheimersdisease AT eckertgunterp combinationofsecondaryplantmetabolitesandmicronutrientsimprovesmitochondrialfunctioninacellmodelofearlyalzheimersdisease |